Eyre Brik V 4
4 · BAXTER INTERNATIONAL INC · Filed Sep 19, 2018
Insider Transaction Report
Form 4
Eyre Brik V
CVP, Hospital Products
Transactions
- Exercise/Conversion
Common Stock, $1 par value
2018-09-17$37.38/sh+42,243$1,579,043→ 107,605 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-17−42,243→ 0 totalExercise: $37.38From: 2018-03-05Exp: 2025-03-03→ Common Stock, $1 par value (42,243 underlying) - Sale
Common Stock, $1 par value
2018-09-17$77.31/sh−78,012$6,031,108→ 58,993 total - Exercise/Conversion
Common Stock, $1 par value
2018-09-17$39.33/sh+29,400$1,156,302→ 137,005 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-17−29,400→ 17,172 totalExercise: $39.33From: 2017-03-03Exp: 2026-03-03→ Common Stock, $1 par value (29,400 underlying)
Footnotes (2)
- [F1]Transaction effected pursuant to a Rule 10b5-1 trading plan entered into on June 14, 2018 by Mr. Eyre with respect to certain vested stock options granted by Baxter International Inc. ("BII") to Mr. Eyre.
- [F2]Price reflects weighted average sales price. Range of prices for transactions are $77.10 through $77.52. Full information regarding the number of shares sold at each separate price will be provided by BII upon request.